Expansion of Elkton, Virginia Manufacturing Facility to Further Increase Merck's HPV Vaccine Supply and Support Broader and Equitable Access Life Science Investing
HALF OF IBS PATIENTS SURVEYED REPORT IBS SYMPTOMS MORE CHALLENGING TO MANAGE IN THE PAST YEAR Pharmaceutical Investing
Bristol Myers Squibb Announces Data from EXPLORER-LTE Demonstrating Sustained Improvements in Clinically Meaningful Cardiovascular Outcomes at Weeks 48 and 84 in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Receiving Mavacamten Pharmaceutical Investing
Mavacamten Demonstrated Significant Reduction in Need for Septal Reduction Therapy in Symptomatic Obstructive HCM Patients in Phase 3 VALOR Trial Pharmaceutical Investing
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma Pharmaceutical Investing
Merck Provides Update on FDA Review of Supplemental Biologics License Application for VAXNEUVANCE for Use in Infants and Children Life Science Investing
Merck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO Was Associated With More Rapid Elimination of Infectious SARS-CoV-2 Than Placebo Life Science Investing
Albert Labs Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia Pharmaceutical Investing
Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply Chain Pharmaceutical Investing
Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential Life Science Investing
